Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Donepezil Acetylcholinesterase Inhibitor Action Pathway
Homo sapiens
Drug Action Pathway
Donepezil is an acetylcholinesterase inhibitor that is used in the treatment of Alzheimer's Disease and dementia. It is administered orally or transdermally, sometimes in combination with memantine in order to treat moderate to severe dementia. Donepezil selectively inhibits the acetylcholinesterase enzyme, by doing so it is believed to enhance cholinergic transmission to relieve the symptoms of Alzheimer and dementia.
References
Donepezil Acetylcholinesterase Inhibitor Pathway References
Sugimoto H: Donepezil hydrochloride: a treatment drug for Alzheimer's disease. Chem Rec. 2001;1(1):63-73. doi: 10.1002/1528-0691(2001)1:1<63::AID-TCR9>3.0.CO;2-J.
Pubmed: 11893059
Yesavage JA, Mumenthaler MS, Taylor JL, Friedman L, O'Hara R, Sheikh J, Tinklenberg J, Whitehouse PJ: Donepezil and flight simulator performance: effects on retention of complex skills. Neurology. 2002 Jul 9;59(1):123-5. doi: 10.1212/wnl.59.1.123.
Pubmed: 12105320
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Downloads
Settings